Charts & intelligence
Fundamentals
Financials
Activity
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Korro Bio Stock Gains After Tough 2025 - New Drug Candidate, Analyst Upgrades Boost Outlook
Korro Bio Early Trial Results Fall Short; Stock Hits New Low